Buy BL Kashyap & Sons, target of Rs 1587: IIFL

Published on Thu, Jul 03, 2008 at 12:42 |  Source : Moneycontrol.com

Updated at Thu, Jul 03, 2008 at 15:31  

3275 Investors following BL Kashyap. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

IIFL has maintained its buy rating on BL Kashyap & Sons with a revised target price of Rs 1587 in its July 1, 2008 research report. "Boosted by strong revenue growth in 4QFY08, B L Kashyap's net profit was ahead of our expectations, despite a 80bps contraction in margins. With an order book of Rs 30 billion and robust order inflow momentum, we expect earnings CAGR of 31% over FY08-10ii. This is significantly lower than management's indication, and reflects our concerns regarding uncertainty on the BPTP order."

"We have tweaked our earnings estimates to marginally increase our revenue estimates and cut our EBITDA margin assumptions by 10bps. This translates into 4% and 2% downward revisions in FY09 and FY10 earnings estimates, respectively. Accordingly, we cut our target price to Rs 1587 from Rs 1623. Maintain BUY," says IIFL's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

For further details click on attachment.......

Attachments : tfp20080701.pdf

  

More on Moneycontrol

Trending News

Business News

Apple rushing to finalize apps for iPad 3 announcement
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

Gammon Infra Q3 Net Sales At `15.2 Cr Vs `13.3 Cr (YoY)

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 17:39

Dismal IIP: What makes experts not so `surprised`?

- in Economy

Interviews

Feb 10 2012, 17:36 | Source: CNBC-TV18

Truck demand sluggish; margins down 80bps: Shriram Trans  

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com